| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of ZC3H3 mRNA | increases expression | 19933214
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ZC3H3 protein | affects expression | 20106945
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ZC3H3 mRNA | decreases expression | 20106945
|
| C014347 |
decitabine |
decitabine results in decreased expression of ZC3H3 mRNA | decreases expression | 19363521
|
| C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of ZC3H3 mRNA] | affects reaction|decreases expression | 19363521
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of ZC3H3 mRNA | affects expression | 17555576
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ZC3H3 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZC3H3 mRNA | affects cotreatment|increases expression | 17942748
|
| D005472 |
Fluorouracil |
Fluorouracil affects the expression of ZC3H3 mRNA | affects expression | 16584549
|
| D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ZC3H3 mRNA | affects cotreatment|increases expression | 17183730
|
| D013629 |
Tamoxifen |
Tamoxifen affects the expression of ZC3H3 mRNA | affects expression | 17555576
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZC3H3 mRNA | affects cotreatment|increases expression | 17942748
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ZC3H3 mRNA | increases expression | 17942748 19933214
|
| D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ZC3H3 mRNA | affects cotreatment|increases expression | 17183730
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.81 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.11 | 15322242 11752688 14514962 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.11 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.10 | 19490988 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.21 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.46 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.46 | 17638652 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.50 | 17688650 |
| MESH:D000740 |
Anemia |
|
Fluorouracil |
9.23 | 16511603 15504547 17963324 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.23 | 11748828 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.71 | 17497229 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.68 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.76 | 15885639 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 20603192 17507914 18940202 17157402 18396377 18558336 15238991 16609825 17688650 18985861 18316065 19232924 18775368 19460635 18177632 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.15 | 20046352 17594078 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.37 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.37 | 8888407 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.98 | 19208741 18320071 |
| MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.98 | 16595493 16110121 19217205 15136595 18608205 18357371 16557594 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.98 | 11161223 18425577 19155303 19115204 18629630 20544844 19244106 19410462 19142967 21138602 18855134 17893378 19103187 17261762 16202921 19288272 18351453 16873071 19189212 18815881 15565566 20390343 19189210 19084267 20859285 19221464 16818667 19487384 17049068 19289846 20005174 18821012 18997820 19066611 18984771 17242785 17440819 19200415 19011961 20065188 21152245 20135344 19059307 16273361 15668708 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.98 | 20435547 |
| MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.93 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.65 | 17121937 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.65 | 16835633 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.72 | 19066611 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.77 | 21507988 12619106 12907637 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
4.77 | 17045692 17971768 16799960 17088986 18930000 16332177 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.77 | 16924424 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.09 | 18695887 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.99 | 19215824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.99 | 16757204 17066447 16280240 18986760 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.78 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 16120746 18850075 18670907 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.64 | 12371664 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.76 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.20 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.20 | 17333356 17110522 15861022 17681005 16919318 16105132 11677210 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 15340226 8697196 16354765 15668235 12621046 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.96 | 17616700 |
| MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.96 | 17169374 15001691 18772588 17725105 16340194 16510598 17018589 17172411 17016597 17287894 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.67 | 18981723 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.67 | 17594712 18383874 18949393 18509181 14970324 16524972 17016601 18448328 17255274 17454858 18288408 17695437 16331619 16391804 15289873 16282729 20501625 18802399 17401013 15148649 17094418 16303861 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.52 | 20055451 15322242 10048152 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.52 | 16575769 8888407 17688650 |
| MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.03 | 16733453 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.58 | 19031437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.63 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.92 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.92 | 1733752 19641884 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.23 | 1851702 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 16714409 15322242 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.62 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.62 | 19031437 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.38 | 19294695 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.15 | 17893378 16202921 19155303 20544844 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.37 | 3659116 17275665 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.18 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.01 | 18234410 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.74 | 6426943 7562514 6254150 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.51 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.30 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.48 | 15173087 16481741 16337965 17638652 16785472 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
20.25 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
20.25 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
20.25 | 14986274 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
20.25 | 14986274 19224547 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.33 | 16709447 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.15 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.33 | 8888407 18558336 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.76 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.42 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12639820 12168785 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
| MESH:D005910 |
Glioma |
|
Fluorouracil |
2.93 | 16145905 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
8.28 | 19215824 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
8.28 | 15102660 15162350 18337622 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 11294989 10048152 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 16120746 12621046 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.10 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 16959395 15340226 16354765 18606429 8697196 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18850075 18670907 |
| MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.84 | 16612254 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.02 | 16569931 16945680 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.65 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
7.09 | 17581917 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.09 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.16 | 19457130 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.16 | 12878042 12200463 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.43 | 8314463 10903974 18776723 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.28 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
13.28 | 16985049 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
13.28 | 18625569 |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.15 | 19235587 18980019 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.17 | 17236224 19117987 18454857 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.09 | 18704418 18206229 17679729 19010910 18460780 19387464 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
4.09 | 17596541 16294345 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.73 | 18055864 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.27 | 17567588 15342952 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.33 | 18564211 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.33 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
11.19 | 2125692 15890375 9163691 18177683 |
| MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
11.19 | 15113037 17045692 18383874 16603448 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
11.19 | 16684651 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.19 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.15 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.15 | 12151625 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.53 | 17228818 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.99 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.99 | 15246190 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.99 | 18625569 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.99 | 11884234 19555203 |
| MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.03 | 15086387 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.54 | 19470736 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.00 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.73 | 19196723 11731420 19196722 16827153 14580682 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.81 | 19453300 |
| MESH:D008545 |
Melanoma |
|
decitabine |
3.48 | 17785578 16505122 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.48 | 19393235 12393984 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.42 | 15990972 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.31 | 18803445 18765137 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.76 | 18986760 16757204 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.46 | 18172295 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.20 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.81 | 18608210 19157545 19010910 16882708 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.81 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.60 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.56 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.52 | 19470736 19116145 17925555 |
| MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.52 | 18239605 16928823 18600527 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.26 | 19196722 19189210 19200415 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.23 | 16359493 8888407 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.55 | 16436463 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.69 | 19259094 19331143 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.63 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.63 | 16500647 16929163 15113037 19003803 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.87 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.27 | 11896295 11399792 11222880 11118676 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.27 | 20603192 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.94 | 17616702 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.25 | 18626508 19082440 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.25 | 15067354 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.55 | 16919318 15861022 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.81 | 11422049 12752131 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
| MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.16 | 16160472 18722050 15538739 18286688 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.60 | 19155313 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
11.60 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
2.85 | 16876388 1511512 14763951 3137016 11044598 17978042 15475178 11738929 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.11 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.46 | 16709447 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.46 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.28 | 19457130 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.91 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.81 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.65 | 19037991 |
| MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.65 | 17522103 15786421 18396642 19084572 16424979 17172411 17498489 16951190 18567086 19015929 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.80 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.30 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.46 | 17967635 |
| MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.15 | 16280240 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.50 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.76 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.39 | 17616700 19087683 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.39 | 16712894 8653321 17572228 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.86 | 8888407 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.04 | 16803524 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.50 | 14692618 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.18 | 17785578 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.71 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |